221 related articles for article (PubMed ID: 11258691)
1. Mometasone furoate: efficacy and safety in moderate asthma compared with beclomethasone dipropionate.
Nathan RA; Nayak AS; Graft DF; Lawrence M; Picone FJ; Ahmed T; Wolfe J; Vanderwalker ML; Nolop KB; Harrison JE
Ann Allergy Asthma Immunol; 2001 Feb; 86(2):203-10. PubMed ID: 11258691
[TBL] [Abstract][Full Text] [Related]
2. Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator.
O'Connor B; Bonnaud G; Haahtela T; Luna JM; Querfurt H; Wegener T; Lutsky BN
Ann Allergy Asthma Immunol; 2001 Apr; 86(4):397-404. PubMed ID: 11345282
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids.
D'Urzo A; Karpel JP; Busse WW; Boulet LP; Monahan ME; Lutsky B; Staudinger H
Curr Med Res Opin; 2005 Aug; 21(8):1281-9. PubMed ID: 16083538
[TBL] [Abstract][Full Text] [Related]
4. Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler.
Noonan M; Karpel JP; Bensch GW; Ramsdell JW; Webb DR; Nolop KB; Lutsky BN
Ann Allergy Asthma Immunol; 2001 Jan; 86(1):36-43. PubMed ID: 11206236
[TBL] [Abstract][Full Text] [Related]
5. Comparison of once-daily mometasone furoate versus once-daily budesonide in patients with moderate persistent asthma.
Corren J; Berkowitz R; Murray JJ; Prenner B
Int J Clin Pract; 2003 Sep; 57(7):567-72. PubMed ID: 14529054
[TBL] [Abstract][Full Text] [Related]
6. Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma.
Karpel JP; Busse WW; Noonan MJ; Monahan ME; Lutsky B; Staudinger H
Ann Pharmacother; 2005 Dec; 39(12):1977-83. PubMed ID: 16264062
[TBL] [Abstract][Full Text] [Related]
7. Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma.
Kemp JP; Berkowitz RB; Miller SD; Murray JJ; Nolop K; Harrison JE
J Allergy Clin Immunol; 2000 Sep; 106(3):485-92. PubMed ID: 10984368
[TBL] [Abstract][Full Text] [Related]
8. Effects of treatment with mometasone furoate dry powder inhaler in children with persistent asthma.
Berger WE; Milgrom H; Chervinsky P; Noonan M; Weinstein SF; Lutsky BN; Staudinger H
Ann Allergy Asthma Immunol; 2006 Nov; 97(5):672-80. PubMed ID: 17165278
[TBL] [Abstract][Full Text] [Related]
9. Comparison of mometasone furoate administered by metered dose inhaler with beclomethasone dipropionate.
Chervinsky P; Nelson HS; Bernstein DI; Berkowitz RA; Siegel SC
Int J Clin Pract; 2002; 56(6):419-25. PubMed ID: 12166539
[TBL] [Abstract][Full Text] [Related]
10. Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma.
Nayak AS; Banov C; Corren J; Feinstein BK; Floreani A; Friedman BF; Goldsobel A; Gottschlich GM; Hannaway PJ; Lampl KL; Lapidus RJ; Lawrence M; Lumry W; Munk Z; Pearlman D; Scardella AT; Schenkel EJ; Segal AT; Segall N; Silverman B; Shneyer L; Nolop KB; Harrison JE
Ann Allergy Asthma Immunol; 2000 Apr; 84(4):417-24. PubMed ID: 10795650
[TBL] [Abstract][Full Text] [Related]
11. Mometasone furoate antagonizes AMP-induced bronchoconstriction in patients with mild asthma.
Holgate ST; Arshad H; Stryszak P; Harrison JE
J Allergy Clin Immunol; 2000 May; 105(5):906-11. PubMed ID: 10808170
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate.
Wardlaw A; Larivee P; Eller J; Cockcroft DW; Ghaly L; Harris AG
Ann Allergy Asthma Immunol; 2004 Jul; 93(1):49-55. PubMed ID: 15281471
[TBL] [Abstract][Full Text] [Related]
13. Once-daily evening administration of mometasone furoate in asthma treatment initiation.
Bensch GW; Prenner B; Berkowitz R; Galant S; Ramsdell J; Lutsky B
Ann Allergy Asthma Immunol; 2006 Apr; 96(4):533-40. PubMed ID: 16680923
[TBL] [Abstract][Full Text] [Related]
14. Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma.
Karpel JP; Nayak A; Lumry W; Craig TJ; Kerwin E; Fish JE; Lutsky B
Respir Med; 2007 Mar; 101(3):628-37. PubMed ID: 16875813
[TBL] [Abstract][Full Text] [Related]
15. Comparable morning versus evening administration of once-daily mometasone furoate dry powder inhaler.
Zetterström O; Dahl R; Lindqvist A; Olsson P
Respir Med; 2008 Oct; 102(10):1406-11. PubMed ID: 18640826
[TBL] [Abstract][Full Text] [Related]
16. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
Chrousos GP; Ghaly L; Shedden A; Iezzoni DG; Harris AG
Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
[TBL] [Abstract][Full Text] [Related]
17. Long-term safety of mometasone furoate administered via a dry powder inhaler in children: Results of an open-label study comparing mometasone furoate with beclomethasone dipropionate in children with persistent asthma.
Noonan M; Leflein J; Corren J; Staudinger H
BMC Pediatr; 2009 Jul; 9():43. PubMed ID: 19594937
[TBL] [Abstract][Full Text] [Related]
18. Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler.
Bernstein DI; Berkowitz RB; Chervinsky P; Dvorin DJ; Finn AF; Gross GN; Karetzky M; Kemp JP; Laforce C; Lumry W; Mendelson LM; Nelson H; Pearlman D; Rachelefsky G; Ratner P; Repsher L; Segal AT; Selner JC; Settipane GA; Wanderer A; Cuss FM; Nolop KB; Harrison JE
Respir Med; 1999 Sep; 93(9):603-12. PubMed ID: 10542973
[TBL] [Abstract][Full Text] [Related]
19. A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthma.
Nathan RA; Pinnas JL; Schwartz HJ; Grossman J; Yancey SW; Emmett AH; Rickard KA
Ann Allergy Asthma Immunol; 1999 Jun; 82(6):521-9. PubMed ID: 10400478
[TBL] [Abstract][Full Text] [Related]
20. Comparison of mometasone furoate dry powder inhaler and fluticasone propionate dry powder inhaler in patients with moderate to severe persistent asthma requiring high-dose inhaled corticosteroid therapy: findings from a noninferiority trial.
Harnest U; Price D; Howes T; Sussman G
J Asthma; 2008 Apr; 45(3):215-20. PubMed ID: 18415829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]